These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21878494)

  • 1. Revolution II--you better change your mind instead. By Caveman.
    J Cell Sci; 2011 Sep; 124(Pt 17):2873-5. PubMed ID: 21878494
    [No Abstract]   [Full Text] [Related]  

  • 2. Preface to the special issue "Novel pharmaconeurogenetic approaches arising from progress in translational genetics".
    Renger JJ; Kern JT
    J Neurogenet; 2011 Dec; 25(4):117-9. PubMed ID: 22074379
    [No Abstract]   [Full Text] [Related]  

  • 3. Research funds should be returned if findings can't be reproduced, proposes Merck chief.
    Mayor S
    BMJ; 2016 Apr; 353():i2477. PubMed ID: 27129727
    [No Abstract]   [Full Text] [Related]  

  • 4. Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living?
    Elliott C
    New Yorker; 2008 Jan; ():36-41. PubMed ID: 18265451
    [No Abstract]   [Full Text] [Related]  

  • 5. Revolution III – one pill makes you small: by Caveman.
    J Cell Sci; 2011 Sep; 124(Pt 18):3039-41. PubMed ID: 22013623
    [No Abstract]   [Full Text] [Related]  

  • 6. Benchmarking the scientific output of the Innovative Medicines Initiative.
    Gunn M; Lim M; Cross D; Goldman M
    Nat Biotechnol; 2015 Aug; 33(8):811-2. PubMed ID: 26252134
    [No Abstract]   [Full Text] [Related]  

  • 7. Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group.
    Anderson DC; Gomez-Mancilla B; Spear BB; Barnes DM; Cheeseman K; Shaw PM; Friedman J; McCarthy A; Brazell C; Ray SC; McHale D; Hashimoto L; Sandbrink R; Watson ML; Salerno RA; Cohen N; Lister CE;
    Pharmacogenomics J; 2002; 2(5):284-92. PubMed ID: 12439734
    [No Abstract]   [Full Text] [Related]  

  • 8. A better Code of Conduct.
    Williams R
    Can Fam Physician; 2005 May; 51():708-9. PubMed ID: 15934276
    [No Abstract]   [Full Text] [Related]  

  • 9. The Academic-Industrial Complexity: Failure to Launch.
    Levin LA; Behar-Cohen F
    Trends Pharmacol Sci; 2017 Dec; 38(12):1052-1060. PubMed ID: 29111229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug representatives: giving you lunch or stealing your soul?
    Higgins SP
    Dermatol Online J; 2007 Oct; 13(4):5. PubMed ID: 18319002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key messages are essential tools in communicating your topic.
    Murphy J; Grant MJ
    Health Info Libr J; 2011 Sep; 28(3):159-60. PubMed ID: 21831214
    [No Abstract]   [Full Text] [Related]  

  • 12. Learning to share.
    Nature; 2010 Jan; 463(7280):401. PubMed ID: 20110941
    [No Abstract]   [Full Text] [Related]  

  • 13. [Collaboration between academia for the development of translational research].
    Nagamura F
    Nihon Yakurigaku Zasshi; 2015 Apr; 145(4):211-5. PubMed ID: 25864833
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates.
    Southan C; Williams AJ; Ekins S
    Drug Discov Today; 2013 Jan; 18(1-2):58-70. PubMed ID: 23159359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical doctors and pharmaceutical industry].
    de Francisco AL
    Nefrologia; 2004; 24(5):393-4. PubMed ID: 15648899
    [No Abstract]   [Full Text] [Related]  

  • 16. Translational medicine: a new creed?
    Henderson S
    Aust N Z J Psychiatry; 2011 Nov; 45(11):920-2. PubMed ID: 22044171
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug samples--there is no free lunch! Minimize your risks and meet your regulatory responsibilities.
    Freeman J
    Iowa Med; 2005; 95(5):10-1. PubMed ID: 16270612
    [No Abstract]   [Full Text] [Related]  

  • 18. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 19. Do drug firms hoodwink medical journals? Or is something wrong with the contribution and integrity of declared authors?
    Wagena EJ; Knipschild P
    J Med Ethics; 2005 May; 31(5):307. PubMed ID: 15863694
    [No Abstract]   [Full Text] [Related]  

  • 20. Open letter (and invitation) to the pharmaceutical industry: "no, we cannot just present your slide deck …".
    Benbadis SR; Faught RE; Hirsch L; Sperling M; Slater J; Sirven J
    Epilepsy Behav; 2010 Nov; 19(3):544-5. PubMed ID: 20833110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.